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Abstract. 
 
Transforming growth factor-
 
b
 
 (TGF
 
b
 
) is a 
dimeric peptide growth factor which regulates cellular 
differentiation and proliferation during development. 
Most cells secrete TGF
 
b
 
 as a large latent TGF
 
b
 
 com-
plex containing mature TGF
 
b
 
, latency associated pep-
tide, and latent TGF
 
b
 
-binding protein (LTBP)-1. The 
biological role of LTBP-1 in development remains 
unclear. Using a polyclonal antiserum specific for 
LTBP-1 (Ab39) and three-dimensional collagen gel 
culture assay of embryonic heart, we examined the tis-
sue distribution of LTBP-1 and its functional role dur-
ing the formation of endocardial cushion tissue in the 
mouse embryonic heart. Mature TGF
 
b
 
 protein was re-
quired at the onset of the endothelial-mesenchymal 
transformation to initiate endocardial cushion tissue 
formation. Double antibody staining showed that 
LTBP-1 colocalized with TGF
 
b
 
1 as an extracellular 
fibrillar structure surrounding the endocardial cushion 
mesenchymal cells. Immunogold electronmicroscopy 
showed that LTBP-1 localized to 40–100 nm extracellu-
lar fibrillar structure and 5–10-nm microfibrils. The 
anti–LTBP-1 antiserum (Ab39) inhibited the endothe-
lial-mesenchymal transformation in atrio-ventricular 
endocardial cells cocultured with associated myocar-
dium on a three-dimensional collagen gel lattice. This 
inhibitory effect was reversed by administration of ma-
ture TGF
 
b
 
 proteins in culture. These results suggest 
that LTBP-1 exists as an extracellular fibrillar structure 
and plays a role in the storage of TGF
 
b
 
 as a large latent 
TGF
 
b
 
 complex.
 
T
 
ransforming
 
 growth factor-
 
b
 
s (TGF
 
b
 
s) are 25-kD
dimeric peptide growth factors and are thought to
regulate the signals by which primary and second-
ary inductions are initiated at different stages of embryo-
genesis in vertebrates. Several TGF
 
b
 
s and their receptors
are expressed in developing organs, and their tissue distri-
bution pattern has possible significance for signaling roles
in epithelial-mesenchymal interaction during embryogene-
sis (Sporn et al., 1986; Barnard et al., 1990; MacLellan et al.,
1993; Akhurst, 1994). Although it is clear that TGF
 
b
 
s are
important molecules in the regulation of cellular differen-
tiation and proliferation, it is still unknown how the activ-
ity of this growth factor is controlled under the physiologi-
cal conditions. The biological activity of TGF
 
b
 
 is thought
to be carefully controlled in a number of ways, via mRNA
expression and protein synthesis, tissue or cellular distri-
bution of receptors, presence of a latent form of TGF
 
b
 
, ac-
tivation of the latent form of TGF
 
b
 
, and inactivation of
the active form (Miyazono et al., 1993, 1994). 
 TGF
 
b
 
 is released from cells in a secretory form consist-
ing of the mature growth factor associated with an NH
 
2
 
-
terminal peptide, a latency associated peptide (LAP)
 
1
 
, and a
latent TGF
 
b
 
-binding protein (LTBP)-1. This complex, the
so-called large latent TGF
 
b
 
 complex, is unable to bind
TGF
 
b
 
 receptors and is physiologically inactive (Pircher et
al., 1986; Lawrence et al., 1985; Miyazono et al., 1991). The
high molecular weight form of the large latent TGF
 
b
 
 com-
plex contains LTBP-1, which is a glycoprotein of more
than 190 kD and associated with the LAP via a disulfide
bond (Miyazono et al., 1988; Wakefield et al., 1988; Sahar-
inen et al., 1996). The mature TGF
 
b
 
 is noncovalently asso-
ciated with the LAP; this complex is called the small latent
TGF
 
b
 
 complex. The dissociation of the LAP renders the
TGF
 
b
 
 biologically active. The large latent TGF
 
b
 
 complex
is activated by proteolysis of the latent complex by plas-
min (Lyons et al., 1988; Sato and Rifkin, 1989; Taipale et
al., 1992). The latent TGF
 
b
 
 is also activated by thrombo-
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1.
 
 Abbreviations used in this paper
 
: AV, atrioventricular; EX, explant;
LAP, latency associated peptide; LTBP, latent transforming growth fac-
tor-
 
b 
 
binding protein; M, myocardium; Me, mesenchymal cell; OT, out-
flow tract; PL, plasmin.
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spondin in certain cell types (Schultz-Cherry and Murphy-
Ullrich, 1993; Souchelnitskiy et al., 1995). 
 There are at least three forms of LTBP (LTBP-1,
LTBP-2, and LTBP-3) which recently have been cloned
and sequenced (Kanzaki et al., 1990; Tsuji et al., 1990;
Moren et al., 1994; Gibson et al., 1995; Yin et al., 1995).
LTBP-1 possesses 16–18 EGF-like domains, two of which
contain hydroxyasparagine posttranscriptional modifica-
tions, and a novel motif containing eight cysteine residues
(Kanzaki et al., 1990; Tsuji et al., 1990). These sequence
characteristics of LTBP are also found in microfibrillar
components, fibrillins, which suggests that LTBPs are in-
volved in protein–protein interaction with cell surface
molecules, as well as with the extracellular matrix (Apella
et al., 1988; Rao et al., 1995). In the case of bovine endo-
thelial cells cocultured with smooth muscle cells, targeting
of the latent TGF
 
b
 
 complex to smooth muscle cells is re-
quired for the activation of latent TGF
 
b
 
. Since LTBP-1
contains structural motifs involved in protein–protein in-
teraction, LTBP-1 is thought to target the large latent
TGF
 
b
 
 complex on the surface of certain cells in the trig-
gering of the biological activity of TGF
 
b
 
. Flaumenhaft et
al. (1993) reported that LTBP-1 may play a role in the acti-
vation of the large latent TGF
 
b
 
 complex on the endothe-
lial cell surface by concentrating the latent complex on the
cell surface. In a model based on a human fibroblast cul-
ture, secreted TGF
 
b
 
1 associates with the extracellular ma-
trix via the targeting mechanism involving LTBP-1 of the
large latent TGF
 
b
 
1 complex. In this model, the association
between LTBP-1 and the extracellular matrix is mainly co-
valent, and the release of latent TGF
 
b
 
 is due to a cleavage
of LTBP-1 by plasmin (Taipale et al., 1992, 1994). It re-
mains unclear what the biological functions and tissue dis-
tributions of LTBP-1 actually are in those regions where
TGF
 
b
 
-dependent cellular differentiation occurs during
development. 
 Epithelial-mesenchymal interaction is one of the most
important embryonic phenomena in the organization of
the body axis, as well as in organogenesis. It is regulated via
genes transcribed in a spatiotemporally restricted manner
during development. Endothelial-mesenchymal transfor-
mation during the formation of endocardial cushion tissue
is one of the most studied examples of epithelial-mesen-
chymal interaction in the embryogenesis (Markwald et al.,
1975, 1977; Krug et al., 1985, 1987; Mjaatvedt and Mark-
wald, 1989; Mjaatvedt et al., 1991; Nakajima et al., 1994,
1996). During its early development, the heart consists of
two concentric epithelial layers, endocardium and myocar-
dium, which are separated by an expanded acellular extra-
cellular matrix (cardiac jelly). As development proceeds,
some of the endothelial cells of both the outflow tract
(OT) and atrioventricular (AV) regions change their phe-
notype to that of mesenchymal cells and migrate into the
adjacent cardiac jelly. This is known as endothelial-mesen-
chymal transformation. It leads to the formation of en-
docardial cushion tissue of the primordia of both the
valves and septa of the adult heart. This endothelial-mes-
enchymal transformation is regulated, at least in part, by
TGF
 
b
 
3 during endocardial cushion tissue formation in the
chicken embryonic heart (Potts et al., 1989, 1991; Naka-
jima et al., 1994). During murine endocardial cushion tis-
sue formation, three TGF
 
b
 
s (TGF
 
b
 
1, TGF
 
b
 
2, and TGF
 
b
 
3)
are preferentially distributed within the cushion tissue-
forming region in the heart, TGF
 
b
 
1 being expressed in en-
dothelial/mesenchymal cells and TGF
 
b
 
2 and 
 
b
 
3 in the
outer myocardium (Akhurst et al., 1990; Dickson et al.,
1993; Mahmood et al., 1992, 1995). Although the tissue
distribution of TGF
 
b
 
s has been well examined at mRNA
and protein levels, the functional significance of TGF
 
b
 
 in
the formation of murine endocardial cushion tissue has yet
to be determined. In addition, the tissue distribution and
functional role of LTBP-1 during cushion tissue formation
remains unknown. 
 Using an antiserum specific for LTBP-1 (Ab39), and an
AV endothelial bioassay employing a three-dimensional
collagen culture system (Bernanke and Markwald, 1982),
we have examined the tissue distribution of LTBP-1 and
its functional role during TGF
 
b
 
-dependent endocardial
cushion tissue formation in the mouse embryonic heart.
Double immunohistochemical staining of antibodies spe-
cific for LTBP-1 (Ab39) and TGF
 
b
 
1 revealed that an
LTBP-1 molecule was codistributed with TGF
 
b
 
1 as a fib-
rillar extracellular matrix in the cushion tissue at the onset
of, or during cushion tissue formation. Immunoelectron
microscopy showed that LTBP-1 was associated with 40–
100 nm fibrillar structures in the extracellular matrix sur-
rounding mesenchymal cells. Ab39 inhibited mesenchymal
formation in the AV endothelial bioassay and this inhibi-
tory effect was reversed by administration of mature
TGF
 
b
 
 proteins. These results suggest that LTBP-1 exists
as an extracellular fibrillar structure and plays a role in the
storage of the latent TGF
 
b
 
 complex during the formation
of the endocardial cushion tissue. 
 
Materials and Methods
 
Materials
 
Rabbit antiserum (Ab39) was raised against native LTBP-1 purified from
human platelets (Kanzaki et al., 1990; Miyazono et al., 1991); it does not
cross-react with LTBP-2 (Moren et al., 1994; Fig. 1). This antiserum did
not cross-react with mouse fibronectin in immunoblot (data not shown).
Rabbit polyclonal antiserum (Ab178) was raised against a synthetic pep-
tide for human LTBP-2 (Moren et al., 1994). A neutralizing antibody,
anti–human TGF-
 
b
 
1 antibody (anti-TGF
 
b
 
1, King Brewing, Kakogawa-
shi, Japan), was raised against human recombinant TGF
 
b
 
1 in rabbit, and
affinity purified. This antibody reacts with TGF
 
b
 
1 and TGF
 
b
 
2 and inhib-
its the TGF
 
b
 
1-induced production of collagen by NRK-49F to 75% of
control at 50 
 
m
 
g/ml (manufacturer’s description). Anti-TGF
 
b
 
1-IgY (R & D
systems, Minneapolis, MN) was raised against recombinant human
TGF
 
b
 
1 in chicken and this antibody shows
 
,
 
2% cross-reactivity with
TGF
 
b
 
2 and TGF
 
b
 
3 in immunoblot (manufacturer’s description). This an-
tibody did not cross-react with LTBP-1 and mouse fibronectin in immuno-
blot (data not shown). A neutralizing antibody against chicken recombi-
nant TGF
 
b
 
3 (anti-TGF
 
b
 
3) raised in goat was purchased from R & D
Systems. This antibody completely neutralizes the TGF
 
b
 
3-dependent in-
hibition of IL-4–dependent thymidine incorporation by HT-2 cells at 10
 
m
 
g/ml, but does not inhibit the activity of TGF
 
b
 
1, TGF
 
b
 
2, or TGF
 
b
 
5
(manufacturer’s description). Recombinant human TGF
 
b
 
1, purified hu-
man TGF
 
b
 
2, and recombinant chicken TGF
 
b
 
3 molecules were purchased
from King Brewing, Nakarai tesque (Tokyo, Japan), and R & D Systems,
respectively. Recombinant human LTBP-1 was generously donated by H.
Ohashi (Kirin Brewery Co. Ltd., Maebashi, Japan). 
 
Animal Breeding
 
ICR (Jcl:ICR) mice were purchased from Japan Clea Co. (Tokyo, Japan).
The mice were kept at 23
 
8
 
C with a 12/12-h light/dark cycle and were al-
lowed free access to water and a standard pellet diet. Females were placed
together with a male for 12 h, and mating was confirmed by the presence 
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of a vaginal sperm plug (day 0 of gestation). On day 9.5, pregnant mice
were sacrificed by cervical dislocation and a Caesarean section performed.
The heart was removed from each embryo and subjected to the experi-
ments described below. 
 
Three-dimensional Collagen Gel Culture of the
AV Region 
 
Hydrated collagen gel (1 mg/ml type I rat-tail collagen; Collaborative Re-
search, Waltham, MA) was prepared in 4-well dishes (Nunc, Roskilde,
Denmark) as described by Bernanke and Markwald (1982). The hearts
from the mouse embryos were collected and placed in Dulbecco’s PBS.
The AV region was dissected out and cut longitudinally to expose the lu-
men, and then placed on the drained collagen gel that had been saturated
with CM199 (CM199; medium 199 containing 5% FBS, 5 
 
m
 
g/ml insulin, 5 
 
m
 
g/
ml transferrin, 5 ng/ml selenium, and streptomycin/penicillin, ITS; Collabo-
rative Research, strept/pen; GIBCO BRL, Gaithersburg, MD, FBS;
SANKO JYUNYAKU, Tokyo). After 12 h incubation, individual cultures
were processed under the various test conditions described below. To ex-
amine the involvement of TGF
 
b
 
s in endothelial-mesenchymal transformation,
AV endothelial cells cocultured with associated myocardium (AV explant)
were incubated with antibodies against TGF
 
b
 
 (anti-TGF
 
b
 
1, anti-TGF
 
b
 
3,
or both antibodies together) in CM199 and the results compared with that
observed with CM199. To determine the biological activity of LTBP-1
during endothelial-mesenchymal transformation, AV explants were treated
with various concentrations of Ab39 in CM199, with CM199 alone, or with
CM199 containing Ab39 and TGF
 
b
 
 protein (TGF
 
b
 
1, TGF
 
b
 
2, or TGF
 
b
 
3).
Cultures were examined under a Hoffman modulation microscope for en-
dothelial outgrowth and for the characteristics of epithelial-mesenchymal
transformation (such as cell hypertrophy, loss of cell–cell contacts, forma-
tion of migratory processes, and mesenchymal invasion). The number of
invading mesenchymal cells is shown as the mean 
 
6
 
SD. In these bioas-
says, an “inhibition of transformation” was considered to have occurred
when the number of invading mesenchymal cells was more than two stan-
dard deviations below the number seen in a control explant cultured with
CM199 alone. The determination of the endothelial outgrowth was mea-
sured with the end of an eyepiece equipped with a grid pattern and classi-
fied as follows: “
 
2
 
”, no endothelial outgrowth surrounding the myocar-
dium; “
 
1
 
”, maximum diameter of endothelial monolayer was less than
twice the maximum diameter of the myocardium; “
 
11
 
”, maximum diam-
eter of endothelial monolayer was more than twice the maximum diame-
ter of the myocardium.
 
Gel Electrophoresis and Immunoblotting
 
Whole embryos (9.5 or 14.5 d) were homogenized in ice-cooled RIPA
buffer (50 mM Tris-HCl at pH 7.2, 150 mM NaCl, 1% NP-40, 0.5% so-
dium deoxycholate). The deoxycholate-insoluble pellet was collected at
8,000 
 
g
 
 for 10 min. The pellet was washed in PBS, and then digested with
plasmin (0.1 U/ml) in PBS for 1 h at 37
 
8
 
C. The resulting supernatant, con-
taining 
 
z
 
50 
 
m
 
g of protein, was concentrated by ultrafiltration (10-kD cut-
off; Millipore, Tokyo), diluted into nonreducing SDS-PAGE solubiliza-
tion buffer (63 mM Tris-HCl at pH 6.8, containing 2% SDS, and 6 M
urea), boiled for 5 min, and subjected to 6% SDS-PAGE (Laemmli, 1970).
Separated proteins were transferred to an Immobilon-P membrane (Milli-
pore, Bedford, MA), nonspecific binding sites were blocked with 5% non-
fat dried milk in Tris buffered saline, and the membrane was incubated
with Ab39 (diluted 1:500) or Ab178 (diluted 1:200). After extensive wash-
ing, immunoreactivity was detected with the aid of an alkaline phos-
phatase–conjugated goat antibody against rabbit IgG (BioRad, Hercules,
CA) and BCIP/NBT. 
 
cDNA Transfection, Metabolic Labeling, 
Immunoprecipitation, and Gel Electrophoresis
 
COS-1 cells were transfected with pSV7d-LTBP-1 (Kanzaki et al., 1990),
pcDNA3-LTBP-2, or pcDNA3 using LIPOFECTAMIN reagent (GIBCO
BRL) following the manufacturer’s recommendation. 2 d after transfec-
tion, cells were rinsed twice with PBS and the culture medium was ex-
changed to methionine- and cysteine-free DMEM supplemented with 0.1
mCi/ml of [35
 
S
 
]methionine and cysteine mixture (Pro-mix, Amersham,
England). After 12 h of metabolic labeling, conditioned media were col-
lected, concentrated, split equally into two tubes, subjected to immuno-
precipitation by Ab39 or anti-LTBP-2 (Ab178) and analyzed by SDS-
PAGE (reducing condition) using 5–20% linear gradient gel as described
previously (Moren et al., 1994). The gels were fixed, dried, and analyzed
with a Fuji BAS 2000 Bio-Imaging Analyzer (FUJIFILM, Tokyo). 
 
Indirect Immunofluorescence Microscopy
 
Embryos (9.5–10.5 d) were equilibrated in a graded series of sucrose solu-
tions (10–20%, wt/vol) in PBS at 4
 
8
 
C for 12 h, embedded in OCT com-
pound (Miles, IN), and frozen in 2-methylbutane cooled over liquid nitro-
gen. Frozen sections (6–8 
 
m
 
m) were cut on a cryostat, mounted on slides
coated with 3-triethoxysilyl propylamine (Merck, Germany), and air
dried. After rinsing in PBS for 15 min, sections were blocked with 1% bo-
vine serum albumin (BSA) in PBS for 1 h, and incubated with primary an-
tibody (Ab39 was diluted 1:500-1,000 in blocking solution) in a moist
chamber for 2 h at room temperature. They were then rinsed in PBS, incu-
bated with a tetramethylrhodamine-5-(and-6)-isothiocyanate (TRITC)-
conjugated goat antibody against rabbit IgG (Cappel, Malvern, PA) for
1 h, rinsed with PBS and coverslipped with the mounting medium (0.2 M
 
N
 
-propylgallate in 10% PBS/90% glycerol). Similarly prepared fresh fro-
zen sections were incubated with plasmin (0.1 U/ml in PBS) at 37
 
8
 
C for 1 h.
The resulting sections were rinsed in PBS for 30 min and stained with
Ab39, as described above. 
The fresh frozen sections were processed for double antibody staining
for anti-TGF
 
b
 
1-IgY and Ab39. Sections were incubated with primary an-
tibody mixture (Ab39, 1:500; anti-TGF
 
b
 
1-IgY, 10 
 
m
 
g/ml in the blocking
solution) for 2 h at room temperature, rinsed in PBS and incubated with
TRITC-conjugated goat antibody against rabbit IgG for 1 h. They were
then rinsed extensively in PBS and stained with fluorescein-5-isothiocyan-
ate (FITC)–conjugated rabbit antibody against chicken IgY (Promega,
Madison, WI), rinsed in PBS, and coverslipped with the mounting me-
dium. The FITC-conjugated rabbit antibody against chicken IgY did not
recognize Ab39-TRITC-conjugated goat antibody against rabbit IgG
complex on tissue sections (data not shown). 
AV explant cultures grown on collagen gels were processed for whole-
mount double immunostaining. Cultures were drained of medium, rinsed
with PBS, fixed with 4% paraformaldehyde in PBS for 1 h, rinsed with
PBS, blocked for 1 h with 1% BSA in PBS, incubated with primary anti-
body mixture (Ab39 and anti-TGF
 
b
 
1-IgY) at 4
 
8
 
C overnight, rinsed with
PBS, incubated with TRITC-conjugated goat antibody against rabbit IgG
for 2 h, rinsed with PBS, incubated with FITC-conjugated rabbit antibody
against chicken IgY, rinsed with PBS, transferred to slides, and cover-
slipped with the mounting medium. Specificity of immunostaining for
LTBP-1 or TGF
 
b
 
1 was confirmed by preincubating the antibody for 30
min with antigen (Ab39 vs purified human LTBP-1 or recombinant hu-
man LTBP-1; anti-TGF
 
b
 
1-IgY vs recombinant human TGF
 
b1). Samples
were observed under a conventional fluorescence microscope (BX60;
OLYMPUS, Tokyo) and photographed using Tmax 400 (Kodak) or
PROVIA 400 (FUJI FILM). The exposure times for FITC and TRITC
images were 32 s and 40 s, respectively. 
Immunogold Electron Microscopy
Post-embedding for indirect immunoelectron microscopy was performed
using the method described by Tamaki and Yamashina (1994). In brief,
the AV region was resected from the heart of each 9.5-d mouse embryo
and fixed with 0.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M
PBS with the aid of microwave irradiation (150 W; 120 s; maximum tem-
perature, 378C). Samples were then fixed for an additional 1 h at 48C,
rinsed in 7% sucrose in PBS for 12 h, and postfixed in 1% OsO4 contain-
ing 1.5% potassium ferrocyanide for 30 min at 48C. Samples were dehy-
drated in a graded ethanol series (20 min at each concentration), embed-
ded in LR White resin (London Resin, Berkshire, UK) after replacement,
and the resin allowed to polymerize for 24 h at 588C. Ultra-thin sections
were cut, mounted on 200-mesh nickel grids, and pretreated for etching
with a saturated aqueous solution of sodium metaperiodate for 30 s fol-
lowed by five subsequent washes in distilled water. Nonspecific binding
sites were blocked with 1% BSA in PBS for 30 min. The sections were in-
cubated with Ab39 (diluted 1:500) for 12 h at 48C, rinsed in PBS, and incu-
bated with a 5-nm colloidal gold-conjugated secondary antibody (Amer-
sham) for 1 h at room temperature. They were rinsed in PBS followed by
distilled water, and stained with uranyl acetate and lead citrate. 
The pre-embedding method for AV-regions was as follows. They were
dissected out from 9.5-d embryos and incubated with Ab39 in 0.1% BSA/
PBS for 12 h at 48C, rinsed in PBS, and incubated in colloidal gold-conju-
gated secondary antibody in 0.1% BSA/PBS at 48C for 12 h. After the ex-
tensive washing in PBS, they were fixed in 2.5% glutaraldehyde/4%The Journal of Cell Biology, Volume 136, 1997 196
paraformaldehyde in PBS for 2 h at 48C and postfixed in 1% OsO4/PBS
for 40 min at 48C. Samples were dehydrated in a graded ethanol series and
embedded in Epon. Ultra-thin sections were cut, mounted on 150-mesh
grids and stained with uranyl acetate and lead citrate. Specificity for im-
munostaining was confirmed by preincubating the antiserum with purified
human LTBP-1 or recombinant human LTBP-1. Samples were observed
using a transmission electron microscope (JEM-100C; JEOL, Tokyo) op-
erated at 80 kV. 
Results
Ab39 Recognizes Mouse LTBP-1 
In this study, we used a polyclonal antiserum (Ab39)
raised against a purified human LTBP-1 (Kanzaki et al.,
1990; Miyazono et al., 1991). It was important to confirm
that Ab39 does not cross-react with LTBP-2 (Moren et al.,
1994) and recognizes mouse LTBP-1 (Nunes et al., 1995).
Radiolabeled conditioned medium obtained from COS-1
cells transfected with human LTBP-1 or LTBP-2 cDNA
was subjected to immunoprecipitation with Ab39 or anti-
LTBP-2 antiserum (Ab178). Resulting immunoprecipitates
were analyzed by gel electrophoresis/BAS 2000. As shown
in Fig. 1, Ab39 immunoprecipitated 205-kD protein (LTBP-1)
in the conditioned medium from COS-1 cells transfected
with human LTBP-1 cDNA, whereas it did not precipitate
any detectable protein in that transfected with human
LTBP-2 cDNA. Ab178 recognized LTBP-2 protein and did
not cross-react with LTBP-1 (Fig. 1). Using these antisera,
we also performed an immunoblot analysis of the plasmin
digest of a deoxycholate insoluble fraction obtained from
homogenizing embryos (9.5 or 14.5 d). Both the 9.5- and
14.5-d embryos contained an Ab39 immunoreactive 190-
kD protein (Fig. 2). Our preliminary immunoblot showed
that Ab178 reacted with a 180-kD band in the extracts of
14.5-d embryos; there was no detectable immunoreactivity
in the extracts of 9.5-d embryos (data not shown). Thus,
Ab39 appears to recognize mouse LTBP-1 and does not
react with mouse LTBP-2. 
TGFb Is Required to Initiate the Formation of 
Endocardial Cushion Tissue 
Before examining the function of LTBP-1 during endocar-
dial cushion tissue formation, we examined whether TGFbs
were required for the initiation of this embryonic phenom-
enon in an AV endothelial coculture with associated myo-
cardium (AV explant) on a three-dimensional collagen gel
lattice. Although there have been studies of the tissue dis-
tribution of TGFbs during mouse endocardial cushion for-
mation, there is no evidence of a regulatory effect of
TGFbs on endothelial-mesenchymal transformation in
mouse embryonic heart. AV explants, containing endocar-
dium and myocardium, were prepared from 9.5-d mouse
embryonic hearts and cultured with or without neutraliz-
ing antibodies against TGFbs in CM199 (Table I). We ad-
ministrated either anti-TGFb1, anti-TGFb3, or both anti-
bodies to the explant culture at an effective concentration
of antibody according to manufacturer’s description. From
each AV explant cultured in CM199 alone, there was an
invasion of mesenchymal cells into the gel lattice and
Figure 1. Specificity of anti–LTBP-1 antiserum (Ab39). COS-1
cells were transfected with human LTBP-1 (BP-1) or LTBP-2
(BP-2) cDNA. The cells were metabolically labeled, and resulting
conditioned medium was immunoprecipitated with Ab39 or anti–
LTBP-2 antiserum (Ab178) and analyzed by SDS-PAGE (5–
20% linear gradient gel) in the presence of dithiothreitol. 
Figure 2. Immunoblot of plasmin
digest of a deoxycholate insoluble
fraction obtained from homoge-
nizing 9.5- or 14.5-d whole em-
bryo probed with anti–LTBP-1
antiserum (Ab39). Deoxycholate
insoluble fraction of whole homog-
enate of the embryos was digested
with plasmin, and the resulting
supernatant containing 50 mg of
protein was electrophoresed (6%
SDS-PAGE) under nonreducing
conditions. Separated proteins
were transferred to Immobilon-P
and stained with Ab39. Ab39 rec-
ognizes a 190-kD band both in
9.5- and in 14.5-d embryo (arrow-
head). 
Table I. Anti-TGFb Antibody Blocking Experiment in Atrio-
Ventricular Explant Culture
Culture
condition
Mesenchymal formation (60 h)
No. of invaded cells
(mean 6 SD)
Transformation
(explants)
%
Control
CM199 (n 5 8) 134 6 30 100
NR 1 NGIg/CM199 136 6 33 100
(n 5 12)
Experimental
Anti-TGFb1 (n 5 8) 97 6 34* 75
Anti-TGFb3 (n 5 8) 141 6 15 100
Anti-TGFb1 1 3 (n 5 8) 66 6 37* 27
Anti-TGFb1 antibody (50 mg/ml) alone, and the combined administration of the anti-
bodies, anti-TGFb1 (50 mg/ml) and anti-TGFb3 (10 mg/ml), both significantly inhib-
ited mesenchymal cell invasion in comparison with control culture (*, P , 0.05.
Mann-Whitney U test). Anti-TGFb3 antibody (10 mg/ml) alone did not. An inhibition
of transformation was defined when the number of invading mesenchymal cells was
less than two standard deviations below the numbers seen in a control culture. CM199,
medium 199 containing 5% FBS; NR 1 NGIg, 50 mg/ml of normal rabbit IgG and 10
mg/ml of normal goat IgG; n, number of explants tested; No., number.Nakajima et al. LTBP-1 in Embryonic Endocardial Cytodifferentiation 197
many mesenchymal cells were observed after 60 h in cul-
ture. An anti-TGFb1 inhibited this mesenchymal invasion:
the number of mesenchymal cells was significantly lower
and the percentage of the explant invaded was reduced to
75% of control. Culture with both anti-TGFb1 and anti-
TGFb3 antibodies completely inhibited mesenchymal for-
mation. However, an anti-TGFb3 antibody alone did not
inhibit mesenchymal formation in the gel lattice. These re-
sults indicate that TGFbs are required for the generation
of the endothelial-mesenchymal transformation. How-
ever, it is still uncertain which TGFbs are involved in en-
dothelial-mesenchymal transformation in vivo during en-
docardial cushion tissue formation.
Large Latent TGFb Complex Is Distributed
as an Extracellular Material in Mouse Endocardial 
Cushion Tissue
At 9.0–9.5 d of gestation, the heart consists of two concen-
tric epithelial layers, endocardium and myocardium, which
are separated by an expanded cardiac jelly. At 9.5–10 d of
gestation, endothelial cells in the OT and AV regions
change their phenotype to that of mesenchymal cells. They
invade into the adjacent cardiac jelly leading to the forma-
tion of endocardial cushion tissue (Markwald et al., 1975,
1977; Kaufman, 1992). 
At the onset of this endothelial-mesenchymal transfor-
mation, a fibrous structure containing LTBP-1–like mole-
cules was observed beneath hypertrophied endothelial
cells, transforming cells, of OT and AV (Fig. 3, a and b). As
development proceeds, endothelially derived mesenchy-
mal cells accumulate within the AV and OT cardiac jelly,
forming endocardial cushion tissue. A fibrillar arrangement
of LTBP-1–like molecule was observed surrounding the
migrating mesenchymal cells within the cushion tissue (Fig.
3, a–d). This Ab39-immunoreactive molecule could be re-
moved by plasmin treatment in nonfixed fresh frozen tis-
sue-sections before incubation with the primary antibody
(Fig. 3, e and f). These results suggested that the fibrillar
arrangement of LTBP-1–like molecule was associated
with the extracellular matrix via the plasmin-sensitive ex-
tracellular matrix binding sequence (Taipale et al., 1994).
The extracellular matrix of mesenchymal tissue surround-
ing the dorsal aorta, gut epithelium, and neural tube also
contained LTBP-1–like molecule (our unpublished obser-
vations). Immunogold electronmicroscopy revealed that a
40–100-nm low electron dense extracellular fibrillar net-
work surrounding the mesenchymal cells was decorated by
Ab39-gold particles (Fig. 4 a). In addition to 40–100-nm
extracellular fibrillar structure, microfibrils having a diam-
eter of 5–10 nm were stained with Ab39 by the pre-embed-
ding method (Fig. 4 b). The immunostaining was blocked
by a preincubation of Ab39 with purified human LTBP-1
(5 mg/ ml; Fig. 3, g and h and 4 c) or recombinant human
LTBP-1 (50 mg/ml; data not shown). 
To determine whether extracellular TGFb1 (Akhurst et
al., 1990) colocalizes with LTBP-1 during the endocardial
cushion tissue formation, we examined immunohis-
tochemical colocalization of TGFb1 and LTBP-1 in tissue
sections (9.75 d embryonic heart) and cultured AV ex-
plants on collagen gel lattice. There are several anti-TGFb1
antibodies, some antibodies are able to detect a cellular
TGFb1, while the others react with extracellular TGFb1
(Thompson et al., 1989). We used anti-TGFb1 IgY, pur-
chased from R & D systems, because this antibody stained
extracellular TGFb1. Fresh frozen sections from 9.75-d
embryos were processed for double immunostaining for
TGFb1 and LTBP-1. Results showed that extracellular
anti-TGFb1 immunoreactive fibers were observed sur-
rounding the mesenchymal cells and the TGFb1-immu-
noreactive materials coincided with Ab39 immunoreactiv-
ity (Fig. 5, a and b). Double antibody staining was also
performed against cultured AV explant on collagen gel
lattice. AV explants were prepared from 9.5-d embryonic
heart and cultured on the gel lattice. After 48 h in culture,
where endothelial-mesenchymal transformation progres-
sively occurred, cultures were fixed and double-stained
with anti-TGFb1 IgY and Ab39. The extracellular fibrillar
codistribution of TGFb1 and LTBP-1 surrounding the in-
vaded mesenchymal cells was observed (Fig. 5, e and f).
The double antibody staining was blocked by preincuba-
tion of an antibody-mixture containing purified human
LTBP-1 (5 mg/ml) and recombinant human TGFb1 (1 mg/ml;
Fig. 5, c and d and g and h). Our present observations indi-
cate that the large latent TGFb complex is distributed as
an extracellular fibrillar matrix in the developing endocar-
dial cushion tissue.
Ab39 Inhibits Mesenchymal Formation in Culture 
To determine whether LTBP-1 was required for the gen-
eration of the endothelial-mesenchymal transformation,
we cultured AV explants from 9.5-d embryonic hearts with
or without the presence of Ab39 in CM199 (Table II). An-
tiserum against LTBP-1 (AB39) inhibited the mesenchy-
mal cell invasion into the gel lattice in a dose-dependent
manner. At a concentration of 1 ml/ml of Ab39 in CM199,
not only the endothelial outgrowth on the gel lattice, but
also mesenchymal invasion into the gel lattice was inhib-
ited, by comparison with culture in CM199 alone (Fig. 6,
a–d) or normal rabbit serum in CM199. At lower concen-
trations of Ab39, only the mesenchymal invasion (number
of invading mesenchymal cells and percentage of explant
transformed into mesenchyme) was inhibited. These re-
sults indicate that LTBP-1 was required for the generation
of the endothelial outgrowth and for endothelial-mesen-
chymal transformation. They also suggest that a smaller
amount of LTBP-1 was required for the formation of the
endothelial outgrowth. 
To resolve the question as to whether LTBP-1 was re-
quired for activation of the latent TGFb complex or as an
extracellular scaffold for mesenchymal cell migration, we
performed an explant culture rescue experiment. In this,
we added TGFb proteins to the above-mentioned neutral-
izing culture experiment with Ab39. The results of this res-
cue experiment are summarized in Table II. The previous
Ab39 neutralizing experiment had indicated that 1 ml/ml of
Ab39 in CM199 completely blocked the mesenchymal cell
invasion into the gel lattice. In the rescue experiment, the
concentration of Ab39 was maintained at 1 ml/ml in
CM199. TGFb1 or TGFb2 each restored the inhibitory ef-
fect of Ab39 at a concentration of 2 ng/ml (Fig. 6, e and f).
The rescue effect of TGFb3 was less than that of TGFb1
or TGFb2. A high concentration of exogenously appliedThe Journal of Cell Biology, Volume 136, 1997 198
Figure 3. Immunohistochemical staining for LTBP-1 in fresh frozen sections of endocardial cushion tissue. (a and b) At the onset of en-
dothelial-mesenchymal transformation (9.5 d), fibrillar LTBP-1–like molecules are distributed beneath the hypertrophied transforming
cell (arrowhead) and surrounding mesenchymal cells (arrows). There is no LTBP-1 beneath the stationary endothelial cells (E). (c and
d) Fibrillar LTBP-1–like molecules are observed surrounding the invaded mesenchymal cells in 10.5 d AV cushion tissue. (e and f) Fresh
frozen section treated with plasmin (PL) and stained with Ab39. Ab39-immunoreactivity disappeared after plasmin digestion. (g and h)
The Ab39-immunostaining was blocked by a pre-incubation with purified human LTBP-1. E, endocardium; M, myocardium; arrows,
mesenchymal cells. b, d, f, and h are light microscopic images of a, c, e, and g. Bar, 200 mm.Nakajima et al. LTBP-1 in Embryonic Endocardial Cytodifferentiation 199
TGFbs (20 ng/ml) did not exert any greater rescue effect
than that observed with 2 ng/ml on the endothelial out-
growth and mesenchymal cell invasion (data not shown).
The results of our culture experiments suggested that
LTBP-1 was required to induce the biological activity of
the mature TGFb, rather than for the erection of an extra-
cellular scaffold during the TGFb-dependent endothelial-
mesenchymal transformation. They also suggested that an
excess amount of TGFb appeared to inhibit both cellular
differentiation and proliferation in this culture model. 
Discussion
Functional Importance of TGFb during the 
Endothelial-Mesenchymal Transformation
Antibodies against TGFbs, which were exogenously ad-
ministered to the AV endocardium cocultured with associ-
ated myocardium, effectively blocked the invasion of mes-
enchymal cells into the collagen gel lattice. Therefore, TGFbs
are presumably required in the endocardium-to-mesen-
Figure 4. Immunogold electron microscopic detection of LTBP-1 in endocardial cushion tissue. (a) A 40–100 nm extracellular fibrillar
network surrounding the invading mesenchymal cell (Me) is decorated with an Ab39-gold-particles complex (arrowheads). (b) Extracel-
lular microfibril is stained with Ab39 (pre-embedding method). (c) The immunoreactivity of Ab39 was blocked by preincubation of an
antibody with purified human LTBP-1. Bar, 0.5 mm.The Journal of Cell Biology, Volume 136, 1997 200
Figure 5. Immunohistochemical colocalization of TGFb1 and LTBP-1 in 9.75-d embryonic heart and cultured atrioventricular (AV) ex-
plant. Double antibody staining for anti-TGFb1 IgY (a, c, e, and g) and anti–LTBP-1 antiserum (Ab39; b, d, f, and h) was performed.
Extracellular fibrillar structures containing TGFb1 (arrowheads in a and e) coincides with LTBP-1 (arrowheads in b and f) surrounding
the AV cushion tissue mesenchymal cells. The immunoreactivities of anti-TGFb1 IgY and AB39 were blocked by preincubation of anti-
body mixture with recombinant human TGFb1 and purified human LTBP-1 (c and d and g and h). Note that an explant (EX in e and f)
containing myocardium, mesenchyme, and endocardium shows immunoreactivity. Bar, 20 mm.Nakajima et al. LTBP-1 in Embryonic Endocardial Cytodifferentiation 201
chymal cell transformation that occurs during cushion tissue
formation. Three different types of TGFb are preferen-
tially expressed in the endocardial cushion tissue-forming
region of the mouse embryonic heart at mRNA and pro-
tein levels. TGFb1 is expressed in both the premigratory
endocardium and invading mesenchymal cells, whereas
TGFb2 and TGFb3 are expressed in the external myocar-
dium (Akhurst et al., 1990; Dickson et al., 1993; Mahmood et
al., 1993 and 1995). In the chicken embryo, TGFb3 is
thought to be involved in endocardial cushion tissue for-
mation because administration of either antisense oligonu-
cleotides or an antibody specific to TGFb3 effectively blocked
mesenchymal formation in a three-dimensional collagen
gel culture model (Potts et al., 1991; Runyan et al., 1993).
The tissue distribution pattern of TGFb3 in the chicken
endocardial cushion tissue-forming region is similar to that
of TGFb1 in the embryonic heart of the mouse (Akhurst
et al., 1990; Choy et al., 1991; Nakajima et al., 1994). In the
development of the mouse heart, it appears that TGFbs do
play a role in eliciting endothelial-mesenchymal transfor-
mation during the formation of endocardial cushion tissue.
However, it is still unclear which TGFb isoform is pre-
dominantly involved in this embryonic phenomenon.
A combined administration of antibodies (anti-TGFb1
and anti-TGFb3) to an AV explant culture inhibited mes-
enchymal formation more effectively than did a single an-
tibody. Furthermore, TGFb1, TGFb2, or TGFb3 all led to
some recovery of the inhibitory effect of Ab39 against en-
dothelial-mesenchymal transformation in an AV explant
culture. It has been reported that there is no obvious car-
diovascular abnormality in the early development of
TGFb1 null (TGFb12/2) embryos (Letterio et al., 1994;
Diebold et al., 1995; Dickson et al., 1995), despite the fact
that TGFb1 is expressed within the developing heart
(Akhurst et al. 1990; Akhurst, 1994; Dickson et al., 1993;
Mahmood et al., 1992, 1995). Furthermore, fetuses from a
TGFb1 null mother are affected with secondary cardiac
muscle hypertrophy caused by severe vascular defects and
defective hematopoiesis within the extra-embryonic meso-
derm of the yolk sac (Letterio et al., 1994; Dickson et al.,
1995). These results, together with our observations, strongly
suggest that there is a functional redundancy of TGFbs in
the formation of endocardial cushion tissue, although
TGFbs are required there during mouse cardiogenesis.
Extracellular Distribution of LTBP-1
Immunohistochemical observation of LTBP-1–like pro-
teins within the developing endocardial cushion tissue
showed that LTBP-1–like molecule was distributed as a
fibrillar structure surrounding mesenchymal cells. Immuno-
gold electronmicroscopy revealed the LTBP-1–like mole-
cule localized to a 40–100-nm fibrillar network structure.
The tissue distribution pattern of this 40–100-nm fibrillar
structure is similar to that of LTBP-2, a component of elas-
tin-associated microfibrils (Gibson et al., 1995). In addi-
tion, LTBP-1 was associated with 5–10-nm microfibrils.
Sequence analysis of LTBPs has revealed a characteristic
of matrix or adhesion molecules (Kanzaki et al., 1990; Tsuji
et al., 1990; Moren et al. 1994; Gibson et al., 1995; Yin et
al., 1995) and they are classified as the fibrillin family of
extracellular matrix proteins (Sakai et al., 1986, 1991;
Maddox et al., 1989; Rosenbloom et al., 1993; Zhang et al.,
1994). Immunohistochemical examination of mature TGFb1
in developing endocardial cushion tissue revealed not only
a cellular distribution, but also an extracellular fibrillar
deposition of TGFb1 (Fig. 5, a and e; Akhurst et al., 1990;
Mahmood et al., 1993, 1995). We showed that the extracel-
lular distribution of mature TGFb1 coincided with that of
LTBP-1 (Figs. 5 b and 6 b). The tissue distribution pattern
of LTBP-1 is similar to that of both tenascin (Akhurst et
al., 1990) and fibronectin (Mjaatvedt et al., 1987). Re-
cently, LTBP-2 was shown to associate with the mi-
crofibrillar component of elastic fibers in the bovine fetal
nuchal ligament and aorta (Gibson et al., 1995). During fe-
tal rat calvarial cell culture formation of extracellular
fibrillar, LTBP-1 is observed and this structure precedes
the presence of type I collagen fibers (Dallas et al., 1995).
In human fibroblast culture, LTBP-1 is associated with cel-
lular fibronectin as a component of extracellular microfibrils
(Taipale et al., 1996). In COS-1 transfected with the
LTBP-1 cDNA, interaction of LTBP-1 with collagen type
I could also be seen (Olofsson et al., 1995). Immunohis-
tochemical colocalization of the extracellular LTBP-1 and
TGFb1, as well as immunoelectron microscopic observa-
tion for LTBP-1 suggest that the large latent TGFb com-
plex is presumably a component of extracellular mi-
crofibrils that are associated with 40-100 nm extracellular
fibrillar network. The tissue distribution pattern of LTBP-1
and mature TGFb1 is compatible with the hypothetical
role of LTBP-1, i.e., that LTBP-1 concentrates/stores
TGFb within those tissues in which TGFb is a prerequisite
for the progression of endothelial-mesenchymal transfor-
mation.
Role for LTBP-1 during Cushion Tissue Formation
The antibody specific for LTBP-1 (Ab39) inhibited the en-
dothelially derived mesenchymal-cell invasion into the
Table II. Anti–LTBP-1 Antiserum (Ab39) Blocking Experiment 
in AV Explant Culture
Culture
condition
Mesenchyme formation (60 h)
Endothelial
outgrowth
No. of invaded cells
(mean 6 SD)
Transformation
(explants)
%
Control
CM199 (n 5 8) 134 6 30 100 11
NRS/CM199 (n 5 5) 121 6 21 100 11
Ab39/CM199
0.01 ml/ml (n 5 10) 92 6 24* 80 11
0.01 ml/ml (n 5 10) 76 6 19* 50 11
1 ml/ml (n 5 11) 15 6 4* 0 1
Ab39 (1 ml/ml)
1TGFb (2 ng/ml)
b1 (n 5 6) 123 6 28 100 11
b2 (n 5 6) 111 6 15 100 11
b3 (n 5 6) 70 6 26* 33 11
Ab39 significantly inhibited mesenchymal cell invasion into the gel lattice (*, P ,
0.05. Mann-Whitney U test). The inhibitory effect was reversed by administration of
TGFb proteins. Explant cultures in CM199 containing Ab39 and mature TGFb1 or
TGFb2 generated mesenchymal cell invasion to a similar extent as to control cultures.
Addition of TGFb3 was less effective than TGFb1 or TGFb2 in rescuing the inhibi-
tory effect of Ab39. CM199, medium 199 containing 5% FBS; NRS, normal rabbit se-
rum; n, number of explants tested; No., number. The Journal of Cell Biology, Volume 136, 1997 202
collagen gel lattice in culture and the inhibition was re-
versed by the exogenous administration of a mature form
of TGFb proteins. Therefore, these results suggested that
LTBP-1 may be required for the activation or concentra-
tion of TGFb within certain regions. Most cells secrete
TGFb as a high molecular mass of latent TGFb which con-
tains the mature growth factor associated with LAP and
LTBP-1 (Kanzaki et al., 1990; Tsuji et al., 1990). Neither
the large latent TGFb complex nor the small latent TGFb
complex has any biological activity as a growth factor. Ac-
tive TGFbs are highly hydrophobic and basic proteins
which are rapidly lost from solution (Brown et al., 1990);
they therefore bind to many proteins with a relatively high
affinity. Matrix components binding active TGFb could
Figure 6. Three-dimensional collagen gel culture of the AV region. AV explants were prepared from 9.5-d mouse embryonic heart and
cultured on the gel lattice. After 12 h incubation, explants were subjected to various culture conditions as described in Materials and
Methods. (a and b) After an additional 48 h in culture with CM199, an endothelial outgrowth (E in a) and mesenchymal cell invasion
into the gel lattice (arrows in b) were both present. (c and d) When explants were cultured with Ab39 (1 ml/ml), endothelial outgrowth
(E in c) and mesenchymal cell invasion (d) into the gel lattice were both inhibited. (e and f) Rescue experiment: AV explant cultured in
the presence of both Ab39 (1 ml/ml) and mature TGFb1 (2 ng/ml) in CM199 showed definite endothelial outgrowth (E in e) and mesen-
chymal cell invasion (arrows in f) in the gel lattice. E, endothelial outgrowth; EX, explant; arrows, mesenchymal cell; a, c, and e, gel
surface; b, d, and f, under the gel surface observed by optical sectioning, Bar, 200 mm.Nakajima et al. LTBP-1 in Embryonic Endocardial Cytodifferentiation 203
have a role in rendering nascently activated TGFb more
soluble and in delivering it to the cell surface receptors
(Lopez-Casillas et al., 1993; Taipale et al., 1994; Dallas et
al., 1995). On the basis of results obtained using hetero-
typic culture of bovine endothelial and smooth muscle
cells, in which targeting of latent TGFb to smooth muscle
cells is required for the activation of latent TGFb, it has
been proposed that delivery of the latent TGFb complex
to the cell surface occurs via LAP or LTBP-1 (Sato et al.,
1993; Flaumenhaft et al., 1993). The mechanism underly-
ing the targeting process such as LAP-mediated activation
remains unknown but mannose 6-phosphate in LAP ap-
pears to play an important role in certain cell types (Den-
nis and Rifkin, 1991). Flaumenhaft et al. (1993) have re-
ported that either the antibody specific to LTBP-1 (Ab39)
or an excess of exogenously applied free LTBP-1 can in-
hibit the activation of latent TGFb. This suggests that
LTBP-1 may participate in the activation of TGFb by con-
centrating the latent TGFb on the cell surface, where acti-
vation occurs. The large latent form of TGFb associates
with the extracellular matrix covalently via LTBP-1 and the
release of the small latent complex from the extracellular
matrix is a consequence of the proteolytic cleavage of
LTBP-1 (Taipale et al., 1993). To date, it remains un-
known which sequences confer this putative targeting mecha-
nism on LTBP-1. Recently, LTBP-1 with a longer NH2-ter-
minal portion (LTBP-1L) has been identified, and this
LTBP-1L binds more effectively to the extracellular ma-
trix than does LTBP-1 (Oloffson et al., 1995). Together
with previously reported results, our observation may sug-
gest a two-step process for the activation for latent TGFb.
In the first step, the secreted large latent TGFb complex
would be targeted to the extracellular matrix via LTBP-1
for the storage/concentration of TGFb. In the second, pro-
teinase-released latent TGFb complex from the matrix
may possibly retarget the TGFb to cell surface binding
sites by some mechanism such as mannose 6-phosphate re-
ceptor. 
In conclusion, during the formation of endocardial cush-
ion tissue formation, the large latent TGFb complex, con-
taining LTBP-1, LAP, and the mature form of TGFb1, is
distributed as an extracellular fibrillar structure surround-
ing cells where TGFb-dependent endothelial-mesenchy-
mal transformation is regulated. LTBP-1 may play a role
in either the storage or concentration of TGFb for the ac-
tivation of TGFb.
K. Miyazono is supported by Japan Heart Foundation & IBM Japan Re-
search Grant Foundation for 1995. 
Received for publication 4 April 1996 and in revised form 5 September
1996. 
References
Akhurst, R.J. 1994. The transforming growth factor b family in vertebrate em-
bryogenesis. In Growth Factors and Signal Transduction in Development.
M. Nilsen-Hamilton, editor. Wiley-Liss, Inc. New York. pp. 97–122.
Akhurst, R.J., S.A. Lehnert, A. Faissner, and E. Duffie. 1990. TGF b in murine
morphogenetic processes: the early embryo and cardiogenesis. Develop-
ment.  108:645–656.
Appella, E., I.T. Weber, and F. Blasi. 1988. Structure and function of epidermal
growth factor-like regions in proteins. FEBS Lett. 231:1-4.
Barnard, J.A., R.M. Lyons, and H.L. Moses. 1990. The cell biology of trans-
forming growth factor b. Biochem. Biophys. Acta. 1032:79–87.
Bernanke D.H., and R.R. Markwald. 1982. Migratory behavior of cardiac cush-
ion tissue cells in a collagen-lattice culture system. Dev. Biol. 91:235–245.
Brown, P.D., L.M. Wakefield, A.D. Levinson, and M.B. Sporn. 1990. Physio-
chemical activation of recombinant latent transforming growth factor-bs 1,
2, and 3. Growth Factors. 3:35–43.
Choy, M., M.T. Armstrong, and P.B. Armstrong. 1991. Transforming growth
factor-b1 localized within the heart of the chick embryo. Anat. Embryol. 183:
345–352.
Dallas, S.L., K. Miyazono, T.M. Skerry, G.R. Mundy, and L.F. Bonewald. 1995.
Dual role for the latent transforming growth factor-b binding protein in stor-
age of latent TGF-b in the extracellular matrix and as structural matrix pro-
tein. J. Cell Biol. 131:539–549.
Dennis, P.A., and D.B. Rifkin. 1991. Cellular activation of latent transforming
growth factor b requires binding to the cation-independent mannose 6-phos-
phate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA.
88:580–584.
Dickson, M.C., H.G. Slager, E. Duffie, C.L. Mummery, and R.J. Akhurst. 1993.
RNA and protein localization of TGF b 2 in the early mouse embryo suggest
an involvement in cardiac development. Development. 117:625–639.
Dickson, M.C., J.S. Martin, F.M. Cousins, A.B. Kulkarni, S. Karlsson, and R.J.
Akhurst. 1995. Defective haematopoiesis and vasculogenesis in transforming
growth factor-b1 knock out mice. Development. 121:1845–1854.
Diebold, R.J., M.J. Eis, M. Yin, I. Ormsby, G.P. Boivin, B.J. Darrow, J.E. Saf-
fitz, and T. Doetschman. 1995. Early-onset multifocal inflammation in the
transforming growth factor b1-null mouse is lymphocyte mediated. Proc.
Natl. Acad. Sci. USA. 92:12215–12219.
Flaumenhaft, R., M. Abe, Y. Sato, K. Miyazono, J. Harpel, C-H. Heldin, and
D.B. Rifkin. 1993. Role of the latent TGF-b binding protein in the activation
of latent TGF-b cocultures of endothelial and smooth muscle cells. J. Cell
Biol. 120:995–1002.
Gibson, M.A., G. Hatzinikolas, E. C. Davis, E. Baker, G.R. Sutherland, and
R.P. Mecham. 1995. Bovine latent transforming growth factor b1-binding
protein 2: immunolocalization to elastin-associated microfibrils. Mol. Cell.
Biol. 15:6932–6942.
Kanzaki, T., A. Olofsson, A. Moren, C. Wernstedt, U. Hellman, K. Miyazono,
L. Claesson-Welsh, and C.-H. Heldin. 1990. TGF-b1 binding protein: a com-
ponent of the large latent complex of TGF-b1 with multiple repeat se-
quences.  Cell. 61:1051–1061.
Kaufman, M.H. 1992. The Atlas of Mouse Development. Academic Press, Lon-
don.
Krug, E.L., R.B. Runyan, and R.R. Markwald. 1985. Protein extracts from early
embryonic hearts initiate cardiac endothelial cytodifferentiation. Dev. Biol.
112:414–426.
Krug, E.L., C.H. Mjaatvedt, and R.R. Markwald. 1987. Extracellular matrix
from embryonic myocardium elicits an early morphogenetic event in cardiac
endothelial differentiation. Dev. Biol. 120:348–355.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature (Lond.). 227:680–685.
Lawrence, D.A., R. Pircher, and P. Jullien. 1985. Conversion of a high molecu-
lar weight latent TGF-b under acidic conditions. Biochem. Biophys. Res.
Commun. 113:1026–1034.
Letterio, J.J., A.G. Gieser, A.B. Kulkarni, N.S. Roche, M.B. Sporn, and A.B.
Roberts. 1994. Maternal rescue of transforming growth factor b knockout.
Science (Wash. DC). 264:1936–1938.
Lyons, R.M., J. Keski-Oja, and H.L. Moses. 1988. Proteolytic activation of la-
tent transforming growth factor-b from fibroblast-conditioned medium. J.
Cell Biol. 106:1659–1665.
Lopez-Casillas, F., J.L. Wrana, and J. Massague. 1993. Betaglycan presents
ligand to the TGF-b signaling receptor. Cell. 73:1435–1444. 
MacLellan, W.R., T. Brand, and M.D. Schneider. 1993. Transforming growth
factor-b in cardiac ontogeny and adaptation. Circ. Res. 73:783-791.
Maddox, B.K., L.Y. Sakai, D.R. Keene, and R.W. Glanville. 1989. Connective
tissue microfibrils. Isolation and characterization of three large pepsin-resis-
tant domains of fibrillin. J. Biol. Chem. 264:21381–21385.
Mahmood, R., K.C. Flanders, and G.M. Morriss-Kay. 1992. Interactions be-
tween retinoids and TGFbs in mouse morphogenesis. Development. 115:67–74. 
Mahmood, R., K.C. Flanders, and G.M. Morriss-Kay. 1995. The effects of reti-
noid status on TGF b expression during mouse embryogenesis. Anat. Em-
bryol. 192:21–33.
Markwald, R.R., T.P. Fitzharris, and W.N. Adams-Smith. 1975. Structural anal-
ysis of endocardial cytodifferentiation. Dev. Biol. 42:160–180.
Markwald, R.R., T.P. Fitzharris, and F.J. Manasek. 1977. Structural develop-
ment of endocardial cushions. Amer. J. Anat. 148:85–120.
Miyazono, K., U. Hellman, C. Wernstedt, and C.-H. Heldin. 1988. Latent high
molecular complex of transforming growth factor b1. J. Biol. Chem. 263:
6407–6415.
Miyazono, K., H. Ichijo, and C.-H. Heldin. 1993. Transforming growth factor-b:
latent forms, binding proteins and receptors. Growth Factors. 8:11–22.
Miyazono, K., P. ten Dijke, H. Ichijo, and C.-H. Heldin. 1994. Receptors for
transforming growth factor-b. Adv. Immunol. 55:181–220.
Miyazono, K., A. Olofsson, P. Colosetti, and C.-H. Heldin. 1991. A role of the
latent TGF-b1-binding protein in the assembly and secretion of TGF-b1.
EMBO (Eur. Mol. Biol. Organ.) J. 10:1091–1101.
Mjaatvedt, C.H., and R.R. Markwald. 1989. Induction of an epithelial mesen-
chymal transition by an in vivo adheron-like complex. Dev. Biol. 136:118–128.
Mjaatvedt, C.H., E.L. Krug, and R.R. Markwald. 1991. An antiserum (ES1)
against a particulate form of extracellular matrix blocks the transition of car-The Journal of Cell Biology, Volume 136, 1997 204
diac endothelium into mesenchyme in culture. Dev. Biol. 145:219–230.
Moren, A., A. Olofsson, G. Stenman, P. Sahlin, T. Kanzaki, L. Claesson-Welsh,
P. ten Dijke, K. Miyazono, and C.-H. Heldin. 1994. Identification and char-
acterization of LTBP-2, a novel latent transforming growth factor-b binding
protein. J. Biol. Chem. 269:32469–32478.
Nakajima, Y., E.L. Krug, and R.R. Markwald. 1994. Myocardial regulation of
transforming growth factor-b expression by outflow tract endothelium in the
early embryonic chick heart. Dev. Biol. 165:615–625.
Nakajima, Y., M. Morishima, M. Nakazawa, and K. Momma. 1996. Inhibition
of outflow cushion mesenchyme formation in retinoic acid-induced complete
transposition of the great arteries. Cardiovasc. Res. 31:E77–85.
Nunes, I., R.H. Shapiro, and D.B. Rifkin. 1995. Characterization of latent TGF-b
activation by murine peritoneal macrophages. J. Immunol. 155:1450–1459.
Olofsson, A., H. Ichijo, A. Moren, P. ten Dijke, K. Miyazono, and C.-H. Heldin.
1995. Efficient association of an amino-terminally extended form of human
latent transforming growth factor-b binding protein with the extracellular
matrix. J. Biol. Chem. 270:31294–31297.
Pircher, R., P. Jullien, and D.A. Lawrence. 1986. b-Transforming growth factor
is stored in human blood platelets as a latent high molecular weight complex.
Biochem. Biophys. Res. Commun. 136:30–37.
Potts, J.D., and R.B. Runyan. 1989. Epithelial-mesenchymal cell transforma-
tion in the embryonic heart can be mediated, in part, by transforming growth
factor b. Dev. Biol. 134:392–401.
Potts, J.D., J.M. Dagle, J.A. Walder, D.L. Weeks, and R.B. Runyan. 1991. Epi-
thelial-mesenchymal transformation of embryonic endothelial cells is inhib-
ited by a modified antisense oligodeoxynucleotide to transforming growth
factor b. Proc. Natl. Acad. Sci. USA. 88:1516–1520.
Rao, Z., P. Handford, M. Mayhew, V. Knott, G.G. Brownlee, and D. Stuart.
1995. The structure of a Ca21-binding epidermal growth factor-like domain:
its role in protein–protein interactions. Cell. 82:131–141. 
Rosenbloom, J., W.R. Abrams, and R. Mecham. 1993. Extracellular matrix 4:
the elastic fiber. FASEB (Fed. Am. Soc. Exp. Biochem.) J. 7:1208–1218. 
Runyan, R.B., J.D. Potts, and D.L. Weeks. 1992. TGF-b3-mediated tissue inter-
action during embryonic heart development. Mol. Repro. Dev. 32:152–159. 
Saharinen, J., J. Taipale, and J. Keski-Oja. 1996. Association of the small latent
transforming growth factor-b with an eight cysteine repeat of its binding pro-
tein LTBP-1. EMBO (Eur. Mol. Biol. Organ.) J. 15:245–253. 
Sakai, L.Y., D.R. Keene, and E. Engvall. 1986. Fibrillin, a new 350-kD glyco-
protein, is a component of extracellular microfibrils. J. Cell Biol. 103:2499–
2509.
Sakai, L.Y., D.R. Keene, R.W. Glanville, and H.P. Bachinger. 1991. Purifica-
tion and partial characterization of fibrillin, a cysteine-rich structural compo-
nent of connective tissue microfibrils. J. Biol. Chem. 266:14763–14770. 
Sato, Y., and D. B. Rifkin. 1989. Inhibition of endothelial cell movement by
pericytes and smooth muscle cells: activation of a latent transforming growth
factor-b1-like molecule by plasmin during co-culture. J. Cell Biol. 109:309–315.
Sato, Y., F. Okada, M. Abe, T. Seguchi, M. Kuwano, S. Sato, A. Furuya, N. Ha-
nai, and T. Tamaoki. 1993. The mechanism for the activation of latent TGF-b
during co-culture of endothelial cells and smooth muscle cells: cell-type spe-
cific targeting of latent TGF–b to smooth muscle cells. J. Cell Biol. 123:1249–
1254.
Schultz-Cherry, S., and J.E. Murphy-Ullrich. 1993. Thrombospondin causes ac-
tivation of latent transforming growth factor-b by endothelial cells by a
novel mechanism. J. Cell Biol. 122:923–932.
Souchelnitskiy, S., E.M. Chambaz, and J.-J. Feige. 1995. Thrombospondins se-
lectively activate one of the two latent forms of transforming growth factor-b
present in adrenocortical cell-conditioned medium. Endocrinology. 136:
5118–5126.
Sporn, M.B., A.B. Roberts, L.M. Wakefield, and R.K. Assoian. 1986. Trans-
forming growth factor-b: biological function and chemical structure. Science
(Wash. DC). 233:532–534.
Taipale, J., K. Koli, and J. Keski-Oja. 1992. Release of transforming growth fac-
tor-b1 from the pericellular matrix of cultured human fibroblasts and fibro-
sarcoma cells by plasmin and thrombin. J. Biol. Chem. 267:25378–25385.
Taipale, J., K. Miyazono, C.-H. Heldin, and J. Keski-Oja. 1994. Latent trans-
forming growth factor-b1 associates to fibroblast extracellular matrix via la-
tent TGF-b binding protein. J. Cell Biol. 124:171–181.
Taipale, J., J. Saharinen, K. Hadman, and J. Keski-Oja. 1996. Latent transform-
ing growth factor-b1 and its binding protein are components of extracellular
matrix microfibrils. J. Histochem. Cytochem. 44:875–889.
Tamaki, H., and S. Yamashina. 1994. Improved method for post-embedding cy-
tochemistry using reduced osmium and LR white resin. J. Histochem. Cy-
tochem. 42:1285–1293.
Thompson, N.L., K.C. Flanders, J.M. Smith, L.R. Ellingsworth, A.B. Roberts,
and M.S. Sporn. 1986. Expression of transforming growth facto-b1 in specific
cells and tissues of adult and neonatal mice. J. Cell Biol. 108:661–669.
Tsuji, T., F. Okada, K. Yamaguchi, and T. Nakamura. 1990. Molecular cloning
of the large subunit of transforming growth factor type b masking protein
and expression of the mRNA in various rat tissues. Proc. Natl. Acad. Sci.
USA. 87:8835–8839.
Wakefield, L.M., D.M. Smith, K.C. Flanders, and M.B. Sporn. 1988. Latent
transforming growth factor-b from human platelets: a high molecular weight
complex containing precursor sequences. J. Biol. Chem. 263:7646–7654.
Yin, W., E. Smiley, J. Germiller, R.P. Mecham, J.B. Florer, R.J. Wenstrup, and
J. Bonadio. 1995. Isolation of a novel latent transforming growth factor-b
binding protein gene (LTBP-3). J. Biol. Chem. 270:10147–10160. 
Zhang, H., S.D. Apfelroth, W. Hu, E.C. Davis, C. Sanguineti, J. Bonadio, R.P.
Mecham, and F. Ramirez. 1994. Structure and expression of fibrillin-2, a
novel microfibrillar component preferentially located in elastic matrices. J.
Cell Biol. 124:855–863.